They can help find different options or make changes to the treatment plan
Moreover, ongoing education and training for healthcare providers regarding the benefits and limitations of GLP-1 therapies are vital
2A-C), IGF-1 caused statistically significant upregulation of CD274 mRNA in all three PCa cell lines (Fig
In a second study in 28 patients with T2DM, the mean 24-h HR was assessed after 12 weeks treatment with exenatide 10 g BID (5 g BID initiation dose for 4 weeks followed by 10 g BID)
The effectiveness and safety of l-carnitine in CVD is unclear, with contradictory evidence showing potential cardiovascular benefits as well as raising safety concerns [3, 5]
Additionally, as part of the EVOKE trials, there are currently phase III trials conducted by Nordisk [62] investigating the use of semaglutide in the treatment of patients with early-stage AD [63]